论文部分内容阅读
目的:分析心血管介入治疗中抗菌药物的使用情况,评估临床药师的作用和影响。方法:分别收集心血管介入患者治疗的临床资料2012年1—6月79份(干预前组)和2013年1—6月85份(干预后组),对比临床药师干预前后抗菌药物的使用率、抗菌药物品种选择的合理性和抗菌药物使用时机和疗程的合理性。结果:干预前抗菌药物的使用率为43.04%(34/79),干预后为34.12%(29/85);预防使用抗菌药物品种选择合理率干预前为66.67%(6/9),干预后为100.00%;预防用药时机及疗程干预前合格率为22.22%(2/9),干预后为66.67%。结论:在心血管介入治疗中,临床药师的干预促进了抗菌药物的合理使用。
OBJECTIVE: To analyze the use of antimicrobial agents in cardiovascular interventions and evaluate the role and influence of clinical pharmacists. Methods: Clinical data of patients with cardiovascular intervention were collected from January to June in 2012 (pre-intervention group) and 85 cases (post-intervention group) from January to June in 2013. The clinical data of antibacterials before and after intervention , The rationality of the selection of antibacterial drugs and the rationality of timing and treatment of antibacterial drugs. Results: The use of antibacterials before intervention was 43.04% (34/79) and 34.12% (29/85) after intervention. The rate of antibacterials selection was 66.67% (6/9) before intervention. After intervention Was 100.00%. The time of preventive medication and the rate of intervention before intervention were 22.22% (2/9) and 66.67% after intervention. Conclusions: Interventions by clinical pharmacists promote rational use of antimicrobial agents in cardiovascular intervention.